About Mankind Pharma Limited (MANKIND)
Mankind Pharma Limited is a Drug Manufacturers - Specialty & Generic company operating in the Healthcare sector.
MANKIND trades on the Indian stock exchanges (NSE/BSE) and is classified as a large-cap stock .
Key Statistics
- Current Price
- ₹2,492.80
- Market Cap
- ₹1.03T
- 52-Week High
- ₹2,642.00
- 52-Week Low
- ₹1,909.70
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
₹1,000 Invested in Mankind Pharma Limited (MANKIND)
How much would ₹1,000 invested in MANKIND be worth today?
What would ₹1,000 invested in MANKIND 1 year ago be worth today?
A ₹1,000 investment in Mankind Pharma Limited (MANKIND) in 2025 would be worth ₹1,025 as of November 2026, representing a +2.5% total return.
What would ₹1,000 invested in MANKIND 3 years ago be worth today?
A ₹1,000 investment in Mankind Pharma Limited (MANKIND) in 2023 would be worth ₹1,410 as of November 2026, representing a +41.0% total return.
What would ₹1,000 invested in MANKIND at IPO be worth today?
A ₹1,000 investment in Mankind Pharma Limited (MANKIND) at IPO would be worth ₹1,753 as of November 2026, representing a +75.3% total return.
Monthly Returns Heatmap
Over the past 3+ years (41 months), Mankind Pharma Limited (MANKIND) has averaged a monthly return of +1.78% with a median return of +0.88%. The stock had 22 positive months (54%) and 19 negative months (46%). The best month in MANKIND's history was June 2023 with a +25.5% return, while the worst was January 2025 at -15.4%. Historically, June tends to be the strongest month (averaging +6.5%), and January the weakest (-6.0%).
MANKIND's longest winning streak was 6 consecutive months of gains, while its longest losing streak was 6 consecutive months of losses. The best full year was 2024 with a cumulative return of +41.7%, and the worst was 2025 at -24.4%.
Annual Returns
Over 3 years of trading history, Mankind Pharma Limited (MANKIND) has delivered an average annual return of +11.69% with a median return of +13.49%. The compound annual growth rate (CAGR) is +7.95%. The stock posted gains in 2 years (67%) and losses in 1 years (33%).
MANKIND's best year was 2024 with a +45.29% gain, while the worst was 2025 at -23.71%. The longest streak of consecutive positive years was 1, and the longest losing streak was 1 years. MANKIND achieved double-digit gains (10%+) in 2 years. It suffered double-digit losses in 1 years.
| Year | Return | Start | End |
|---|---|---|---|
| 2026 | +13.49% | ₹2,196.50 | ₹2,492.80 |
| 2025 | -23.71% | ₹2,879.26 | ₹2,196.50 |
| 2024 | +45.29% | ₹1,981.72 | ₹2,879.26 |
Frequently Asked Questions: MANKIND
What sector is MANKIND in? ▼
MANKIND operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry. This sector includes pharmaceutical companies, biotechnology firms, medical device manufacturers, and healthcare providers.
How has MANKIND performed historically? ▼
Over 3 years of trading history, MANKIND has posted gains in 2 years (67% of the time). The best year was 2024 with a +45.3% return. Past performance does not guarantee future results.
How can I invest in MANKIND? ▼
You can invest in MANKIND through any brokerage account that offers access to Indian exchanges. Popular options include commission-free brokers like Fidelity, Charles Schwab, or Robinhood (US), or international brokers like Interactive Brokers. You can buy individual shares or invest through ETFs that hold MANKIND.
Last updated: 11/1/2026